Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46,151
datasets available to search
ShareScore release 0.7.1
Dataset results
46,151 results for “Safety”
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
ClinicalTrials.gov study NCT02228096. IPD Sharing: YES. Countries: 1. Publications: 4.
Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
ClinicalTrials.gov study NCT02586805. IPD Sharing: YES. Countries: 7. Publications: 4.
Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo
ClinicalTrials.gov study NCT02798211. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
ClinicalTrials.gov study NCT03691610. IPD Sharing: YES. Countries: 2. Publications: 0.
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PA
ClinicalTrials.gov study NCT03988634. IPD Sharing: YES. Countries: 2. Publications: 6.
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers
ClinicalTrials.gov study NCT03205358. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
ClinicalTrials.gov study NCT04921969. IPD Sharing: YES. Countries: 2. Publications: 0.
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
ClinicalTrials.gov study NCT02962895. IPD Sharing: YES. Countries: 19. Publications: 1.
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines
ClinicalTrials.gov study NCT05032157. IPD Sharing: YES. Countries: 18. Publications: 1.
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
ClinicalTrials.gov study NCT03345836. IPD Sharing: YES. Countries: 48. Publications: 7.
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov study NCT03578367. IPD Sharing: YES. Countries: 15. Publications: 1.
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Anti
ClinicalTrials.gov study NCT03738215. IPD Sharing: YES. Countries: 7. Publications: 1.
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
ClinicalTrials.gov study NCT03855137. IPD Sharing: YES. Countries: 17. Publications: 10.
Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
ClinicalTrials.gov study NCT03627091. IPD Sharing: YES. Countries: 34. Publications: 1.
Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria
ClinicalTrials.gov study NCT03328897. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges
ClinicalTrials.gov study NCT02336451. IPD Sharing: YES. Countries: 17. Publications: 1.
Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
ClinicalTrials.gov study NCT02954458. IPD Sharing: NO. Countries: 6. Publications: 0.
A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment
ClinicalTrials.gov study NCT01610336. IPD Sharing: YES. Countries: 14. Publications: 1.
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines
ClinicalTrials.gov study NCT05030311. IPD Sharing: YES. Countries: 19. Publications: 1.
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon
ClinicalTrials.gov study NCT03869866. IPD Sharing: YES. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.